Abstract:Photodynamic therapy (PDT), characterized by high treatment efficiency, absence of drug resistance, minimal trauma, and few side effects, has gradually emerged as a novel and alternative clinical approach compared to traditional surgical resection, chemotherapy and radiation. Whereas, considering the limited diffusion distance and short lifespan of reactive oxygen species (ROS), as well as the hypoxic tumor microenvironment, it is crucial to design photosensitizers (PSs) with suborganelle specific targeting ability and low-oxygen dependence for accurate and highly efficient photodynamic therapy. In this study, we have meticulously designed three PSs, namely CIH, CIBr, and CIPh, based on molecular engineering. Theoretical calculation demonstrate that the three compounds possess good molecular planarity with calculated S1-T1 energy gaps (ΔES1-T1) of 1.04 eV for CIH, 0.92 eV for CIBr, and 0.84 eV for CIPh respectively. Notably, CIPh showcases remarkable dual subcellular targeting capability towards lipid droplets (LDs) and mitochondria owing to the synergistic effect of lipophilicity derived from coumarin's inherent properties combined with electropositivity conferred by indole salt cations. Furthermore, CIPh demonstrates exclusive release of singlet oxygen (1O2)and highly efficient superoxide anion free radicals(O2⦁-) upon light irradiation supported by its smallest S1-T1 energy gap (ΔES1-T1 = 0.84 eV). This leads to compromised integrity of LDs along with mitochondrial membrane potential, resulting in profound apoptosis induction in HepG2 cells. This successful example of molecular engineering guided by density functional theory (DFT) provides valuable experience for the development of more effective PSs with superior dual targeting specificity. It also provides a new idea for the development of advanced PSs with efficient and accurate ROS generation ability towards fluorescence imaging-guided hypoxic tumor therapy.

Coumarin-Quinazolinone based photosensitizers: Mitochondria and endoplasmic reticulum targeting for enhanced phototherapy via different cell death pathways

Phototherapeutic applications of benzophenone-containing NIR-emitting photosensitizers based on different receptor modulations

Aggregation-induced Emission Near-Infrared Photosensitizer with Time-Responsive Dual-Organelles Targeting for Accelerating Cancer Cells Apoptosis and Metastasis Inhibition

Organelle-Targeted Photosensitizers for Precision Photodynamic Therapy

A Flim Photosensitizer: Targeting “affinal” Suborganelles to Accelerate Cancer Cell Oxidative Stress and Apoptosis

Enhanced Photodynamic Efficiency Achieved Via a Dual-Targeted Strategy Based on Photosensitizer/Micelle Structure

Tuning the Hydrophobicity of Pyridinium-Based Probes to Realize the Mitochondria-Targeted Photodynamic Therapy and Mitophagy Tracking

A Mitochondria‐Targeted Photosensitizer for Combined Pyroptosis and Apoptosis with NIR‐II Fluorescence/Photoacoustic Imaging‐Guided Phototherapy

Molecular engineering to elevate reactive oxygen species generation for synergetic damage on lipid droplets and mitochondria

Mitochondria-Targeting Boron Dipyrromethene Based Photosensitizers for Enhanced Photodynamic Therapy: Synthesis, Optical Properties, and in Vitro Biological Activity.

NIR Photoactivated Electron Intersystem Crossing to Evoke Calcium-Mediated Lysosome-Dependent Cell Death and Immunotherapy

An Aggregation-Induced Emission Photosensitizer with Efficient Singlet Oxygen Generation Capacity for Mitochondria Targeted Photodynamic Therapy

Benzophenone core based AIE-active Photosensitizers for mitochondria-targeted photodynamic therapy

Synthesis and evaluation of novel mitochondria-targeted, water-soluble phenoxazine-porphyrins for efficient photodynamic therapy

A Mitochondria‐Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects under Hypoxia

Recent advances in organelle-targeted organic photosensitizers for efficient photodynamic therapy

Development of Mitochondria‐Targeting Photosensitizers via Topoisomerase I Inhibition

A protein-conjugated photosensitizer with mitochondrial targeting for enhanced photodynamic therapy

Cyclometalated Ir(III) Complexes as Mitochondria-Targeted Photodynamic Anticancer Agents

Synergetic Pyroptosis with Apoptosis Improving Phototherapy of Mitochondria-Targeted Cyanines with Superior Photostability

Boosting the Photodynamic Therapy Efficiency with a Mitochondria-Targeted Nanophotosensitizer